Literature DB >> 2430969

Interaction of vitronectin with collagen.

C Gebb, E G Hayman, E Engvall, E Ruoslahti.   

Abstract

Purified human plasma vitronectin was demonstrated to bind to type I collagen immobilized on plastic as measured by enzyme-linked immunosorbent assay and by binding of 125I-radiolabeled vitronectin to a collagen-coated plastic surface. Vitronectin did not bind to immobilized laminin, fibronectin, or albumin in these assays. Vitronectin showed similar interaction with all types of collagen (I, II, III, IV, V, and VI) tested. Collagen unfolded by heat treatment bound vitronectin less efficiently than native collagen. Vitronectin-coated colloidal gold particles bound to type I collagen fibrils as shown by electron microscopy. Salt concentrations higher than physiological interfered with the binding of vitronectin to collagen, suggesting an ionic interaction between the two proteins. Binding studies conducted in the presence of plasma showed that purified vitronectin added to plasma bound to immobilized collagen, whereas the endogenous plasma vitronectin bound to collagen less well. Although fibronectin did not interfere with the binding of vitronectin to native collagen, vitronectin inhibited the binding of fibronectin to collagen. These results show that vitronectin has a collagen-binding site(s) which, unlike that of fibronectin, preferentially recognizes triple-helical collagen and that the binding between vitronectin and collagen has characteristics compatible with the occurrence of such an interaction in vivo.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2430969

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

1.  Endogenous cleavage of the Arg-379-Ala-380 bond in vitronectin results in a distinct conformational change which 'buries' Ser-378, its site of phosphorylation by protein kinase A.

Authors:  D Chain; B Korc-Grodzicki; T Kreizman; S Shaltiel
Journal:  Biochem J       Date:  1991-03-01       Impact factor: 3.857

2.  Vitronectin-binding staphylococci enhance surface-associated complement activation.

Authors:  F Lundberg; T Lea; A Ljungh
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

3.  Immunohistochemical demonstration of vitronectin in association with elastin and amyloid deposits in human kidney.

Authors:  K Dahlbäck; H Löfberg; B Dahlbäck
Journal:  Histochemistry       Date:  1987

4.  Evidence for a role of collagen synthesis in arterial smooth muscle cell migration.

Authors:  E F Rocnik; B M Chan; J G Pickering
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

5.  Vitronectin (serum spreading factor): its localisation in normal and fibrotic tissue.

Authors:  J T Reilly; J R Nash
Journal:  J Clin Pathol       Date:  1988-12       Impact factor: 3.411

6.  Immunohistochemical localization of S protein/vitronectin in human atherosclerotic versus arteriosclerotic arteries.

Authors:  C Guettier; N Hinglais; P Bruneval; M Kazatchkine; J Bariety; J P Camilleri
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

7.  The Peculiar Pattern of Type IV Collagen Deposition in Epiretinal Membranes.

Authors:  Marì Regoli; Gian Marco Tosi; Giovanni Neri; Annalisa Altera; Daniela Orazioli; Eugenio Bertelli
Journal:  J Histochem Cytochem       Date:  2019-12-20       Impact factor: 2.479

8.  uPA binding to PAI-1 induces corneal myofibroblast differentiation on vitronectin.

Authors:  Lingyan Wang; Christine M Ly; Chun-Ying Ko; Erin E Meyers; Daniel A Lawrence; Audrey M Bernstein
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-13       Impact factor: 4.799

9.  MALDI-mass spectrometry imaging identifies vitronectin as a common constituent of amyloid deposits.

Authors:  Martin Winter; Andreas Tholey; Sandra Krüger; Hartmut Schmidt; Christoph Röcken
Journal:  J Histochem Cytochem       Date:  2015-06-22       Impact factor: 2.479

10.  Binding of vitronectin and clusterin by coagulase-negative staphylococci interfering with complement function.

Authors:  D Q Li; F Lundberg; A Ljungh
Journal:  J Mater Sci Mater Med       Date:  2001 Oct-Dec       Impact factor: 3.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.